Abstract
Statins have plausible biological effects against prostate cancer cells and are associated with improved disease-specific mortality. In current randomized placebo-controlled trial, low-dose atorvastatin caused no difference in relapses after radical prostatectomy in Asian men. Future trials should study higher statin doses at later disease stages with survival as the endpoint. See related article by Jeong et al., p. 5004
| Original language | English |
|---|---|
| Pages (from-to) | 4947-4949 |
| Number of pages | 3 |
| Journal | Clinical Cancer Research |
| Volume | 27 |
| Issue number | 18 |
| DOIs | |
| Publication status | Published - 2021 |
| Publication type | B1 Journal article |
ASJC Scopus subject areas
- Oncology
- Cancer Research
